Esophageal Neoplasm Clinical Trial
Official title:
A Phase III, Multicenter Randomized Controlled Study of Neo-adjuvant Chemotherapy Paclitaxel + Cisplatin Versus Surgery Alone for Stage IIA-IIIB Esophageal Squamous Cell Carcinoma
The effect of neo-adjuvant chemotherapy on survival of patients with thoracic esophageal squamous cell carcinomas remains the most controversial part of neo-adjuvant therapy for esophageal carcinomas. One of our objectives is to evaluate whether the neo-adjuvant therapy with cisplatin and paclitaxel followed by right thoracic approach esophagectomy with total 2-field lymph node dissection improves the overall survival of thoracic esophageal cancer patients.
The effect of Neo-adjuvant chemotherapy on survival of patients with thoracic esophageal squamous cell carcinomas remains the most controversial part of Neo-adjuvant therapy for esophageal carcinomas. Therefore, the optimal management of resectable esophageal squamous cell carcinomas differs widely among different areas based on local randomized controlled trials. The neo-adjuvant chemotherapy might be a good strategy if sufficient local control is achieved by surgical treatment. This study defined the detail of surgery procedure and the region of lymphadenectomy and adopted cisplatin and paclitaxel as neoadjuvant chemotherapy regimens. We try to evaluate the efficacy and safety of this neo-adjuvant strategy. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05176002 -
Camrelizumab in Combination With Radiotherapy for Neoadjuvant Esophageal Carcinoma.
|
Phase 1/Phase 2 | |
| Not yet recruiting |
NCT05406024 -
Feasibility Study CORPPS
|
||
| Terminated |
NCT02601079 -
Endodrill vs. Conventional Biopsy. Diagnostics and Genetic Analysis
|
N/A | |
| Active, not recruiting |
NCT01745107 -
Efficacy of Intensity Modulated Radiation Therapy After Surgery in Early Stage of Esophageal Carcinoma;
|
Phase 3 | |
| Active, not recruiting |
NCT02969473 -
Definitive Concurrent Chemoradiotherapy With Docetaxel Plus Cisplatin Versus 5-fluorouracil Plus Cisplatin in Patients With Esophageal Squamous Cell Carcinoma
|
Phase 2 | |
| Recruiting |
NCT04481100 -
CCRT With Itraconazole in Locally Advanced Squamous Esophageal Cancer
|
Phase 2 | |
| Terminated |
NCT03108885 -
Measuring Cell Free DNA During the Course of Treatment for Esophageal Cancer as a Marker of Response and Recurrence
|
||
| Recruiting |
NCT00288119 -
Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma
|
||
| Terminated |
NCT01870791 -
Study of Additive Omega-3 Fish Oil to Palliative Chemotherapy to Treat Oesophagogastric Cancer
|
Phase 2 | |
| Active, not recruiting |
NCT00431756 -
Novel Biomarkers in the Neoplastic Progression of Barrett's Esophagus
|
||
| Not yet recruiting |
NCT05736705 -
Monopolar and Bipolar in Esophageal ESD
|
N/A | |
| Completed |
NCT02033213 -
Volume Restriction in Esophageal Carcinoma Surgery: Randomized Clinical Trial
|
N/A | |
| Terminated |
NCT00653107 -
Palliation Dysphagia Cancer Oesophagus Stent+Brachytherapy Versus Brachytherapy Only
|
Phase 3 | |
| Completed |
NCT01927016 -
Outcomes After Esophageal Cancer Surgery
|
N/A | |
| Completed |
NCT02558504 -
Radiofrequency in the Treatment of Barrett's Oesophagus
|
Phase 4 | |
| Active, not recruiting |
NCT02636088 -
Definitive Chemoradiotherapy and Cetuximab in the Treatment of Locally Advanced Esophageal Cancer
|
Phase 2 | |
| Terminated |
NCT00423150 -
Phase 2 Study of Temozolomide in Pre-Selected Advanced Aerodigestive Tract Cancers (Study P04273AM2)(TERMINATED)
|
Phase 2 | |
| Completed |
NCT00318903 -
Irinotecan and Taxotere With Radiotherapy as Preoperative Treatment in Resectable Esophageal Cancer
|
Phase 2 | |
| Recruiting |
NCT02583087 -
ESD for the Treatment of Early Barrett's Neoplasia
|
N/A | |
| Active, not recruiting |
NCT04489368 -
Response Prediction to Neoadjuvant Chemoradiation in Esophageal Cancer Using Artificial Intelligence & Machine Learning
|